Other
Neoplasm by Morphology
CI-CAN-00000002Explore in graph →
Non-malignant13,325 active trials222 approved drugs2,774 evidence items
- NCIt
- C4741
Loading cancer entity…
Loading cancer entity…
Other
CI-CAN-00000002Explore in graph →
Clinical trials
52,671 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT01760811 | CETUXIMAB Given for 3 Weeks as Neoadjuvant Treatment in Locally Advanced Tongue Cancer ; A NEW PARADIGM OF TREATMENT | unknown | Phase 1 / Phase 2 | 25 | Rabin Medical CenterOTHER | 1 | Jan 4, 2013 | clinicaltrials |
| NCT01755923 | Gefitinib or Docetaxel as Second Line Therapy for Wild-type Epidermal Growth Factor Receptor (EGFR) NSCLC | unknown | Phase 2 | 60 | Peking Union Medical College HospitalOTHER | 1 | Dec 24, 2012 | clinicaltrials |
| NCT01567930 | Temsirolimus as Second-line Therapy in HCC | unknown | Phase 2 | 25 | University of Tennessee Cancer InstituteOTHER | 1 | Dec 17, 2012 | clinicaltrials |
| NCT01749072 | Vinorelbine-ifosfamide Versus Gefitinib for EGFR Gene Mutation Negative Non-small Cell Lung Cancer Patients | unknown | Phase 2 | 120 | Peking Union Medical College HospitalOTHER | 1 | Dec 13, 2012 | clinicaltrials |
| NCT01392131 | Safety and Efficacy of Oncoxin in Hepatocellular Carcinoma (HCC) | unknown | Phase 1 / Phase 2 | 40 | Clinical Research Organization, Dhaka, BangladeshOTHER | 1 | Dec 12, 2012 | clinicaltrials |
| NCT01746277 | Study of Chemotherapy Sequenced by or Combined With EGFR-TKIs for NSCLC Patients Failed to EGFR-TKIs Therapy | unknown | Phase 2 | 60 | Peking Union Medical College HospitalOTHER | 1 | Dec 10, 2012 | clinicaltrials |
| NCT01742767 | Cisplatinum/Pemetrexed Versus Split-dose Cisplatinum/Pemetrexed In NSCLC(PemSplitCisp) | unknown | Phase 2 | — | Universität Duisburg-EssenOTHER | 1 | Dec 5, 2012 | clinicaltrials |
| NCT01737346 | Procarbazine and Lomustine in Recurrent Glioblastoma | unknown | Phase 2 | 52 | Incheon St.Mary's HospitalOTHER | 1 | Dec 3, 2012 | clinicaltrials |
| NCT01739634 | The Efficacy of CASAD in Patients With Diarrhea Related to Medullary Thyroid Cancer | unknown | Phase 1 / Phase 2 | 10 | Salient Pharmaceuticals IncorporatedINDUSTRY | 1 | Dec 3, 2012 | clinicaltrials |
| NCT01227239 | Preoperative S-1/OHP With Radiation Therapy for Low-lying Rectal Carcinoma in Neo-adjuvant Setting | unknown | Phase 1 / Phase 2 | 45 | Japan Clinical Cancer Research OrganizationOTHER | 1 | Nov 27, 2012 | clinicaltrials |
| NCT00843934 | Trial of Transcatheter Arterial Chemoembolization for Hepatocellular Carcinoma(ACE500) | unknown | Phase 2 / Phase 3 | 450 | Nihon UniversityOTHER | 1 | Oct 19, 2012 | clinicaltrials |
| NCT01218594 | Curative Effect Study of Endostatin Combined With Chemoradiotherapy to Non-small-cell Lung Cancer(DP-EN-RT) | unknown | Phase 2 | 50 | Sun Yat-sen UniversityOTHER | 1 | Oct 17, 2012 | clinicaltrials |
| NCT01655641 | Study of Tranexamic Acid for Reducing Blood Requirement in Patients Undergoing Major Gastro-intestinal Surgery(TMGS) | unknown | Phase 2 / Phase 3 | 118 | Tribhuvan University Teaching Hospital, Institute Of Medicine.OTHER | 1 | Oct 16, 2012 | clinicaltrials |
| NCT01331915 | Safety and Toxicity Study of Vaccination for Advanced Metastatic Melanoma Patients(THERAVAC) | unknown | Phase 1 / Phase 2 | 23 | Cliniques universitaires Saint-Luc- Université Catholique de LouvainOTHER | 1 | Oct 10, 2012 | clinicaltrials |
| NCT01688700 | Study of Nimotuzumab in Combination With Neoadjuvant Chemotherapy for Resectable Esophageal Squamous Cell Carcinoma | unknown | Phase 2 | 60 | Zhejiang Cancer HospitalOTHER | 1 | Sep 20, 2012 | clinicaltrials |
| NCT01688713 | Phase II Trial of Double Dose of Icotinib in Treating Brain Metastases From Non-small Cell Lung Cancer | unknown | Phase 2 | 20 | Zhejiang Cancer HospitalOTHER | 1 | Sep 20, 2012 | clinicaltrials |
| NCT01037556 | PR104 in Treating Patients With Refractory/Relapsed Acute Leukemia | unknown | Phase 1 / Phase 2 | 50 | Proacta, IncorporatedINDUSTRY | 1 | Aug 31, 2012 | clinicaltrials |
| NCT00397800 | Rituximab, Fludarabine, Cyclophosphamide, and Yttrium Y 90 Ibritumomab Tiuxetan in Treating Patients With Relapsed B-Cell Non-Hodgkin's Lymphoma | unknown | Phase 1 / Phase 2 | 12 | Technical University of MunichOTHER | 1 | Aug 28, 2012 | clinicaltrials |
| NCT01670890 | Efficacy and Safety of TMZ Plus CDDP in the Patients With Recurrent Malignant Gliomas | unknown | Phase 2 | 120 | Peking Union Medical College HospitalOTHER | 1 | Aug 22, 2012 | clinicaltrials |
| NCT01665001 | Personalized Therapy of Precursor Lymphoid Neoplasms | unknown | Phase 2 | 200 | Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, GliwiceOTHER | 1 | Aug 17, 2012 | clinicaltrials |
| NCT01665014 | Total Marrow Irradiation and High-dose Melphalan for Double Autologous Hematopoietic Stem Cell Transplantation in Multiple Myeloma | unknown | Phase 2 | 50 | Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, GliwiceOTHER | 1 | Aug 17, 2012 | clinicaltrials |
| NCT00772655 | Zevalin® First Line in Follicular Lymphoma | unknown | Phase 2 | 60 | Charite University, Berlin, GermanyOTHER | 0 | Aug 2, 2012 | clinicaltrials |
| NCT01655628 | GC Regimen Chemotherapy Plus CIK Cells for Metastatic Nasopharyngeal Carcinoma | unknown | Phase 2 | 40 | Sun Yat-sen UniversityOTHER | 1 | Aug 2, 2012 | clinicaltrials |
| NCT01655888 | The Anti-CTLA-4 Monoclonal Antibody Tremelimumab in Malignant Mesothelioma | unknown | Phase 2 | 29 | Azienda Ospedaliera Universitaria SeneseOTHER | 1 | Aug 2, 2012 | clinicaltrials |
| NCT00503594 | Methotrexate and Temozolomide Versus Methotrexate, Procarbazine, Vincristine and Cytarabine(CNSLymphoma) | unknown | Phase 2 | 92 | Assistance Publique - Hôpitaux de ParisOTHER | 1 | Jul 30, 2012 | clinicaltrials |
| NCT01649024 | A Clinical Study With Tremelimumab as Monotherapy in Malignant Mesothelioma | unknown | Phase 2 | 29 | Azienda Ospedaliera Universitaria SeneseOTHER | 1 | Jul 25, 2012 | clinicaltrials |
| NCT00091234 | Gemtuzumab Ozogamicin in Treating Older Patients With Previously Untreated Acute Myeloid Leukemia(AML-19) | unknown | Phase 2 / Phase 3 | 279 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 3 | Jul 24, 2012 | clinicaltrials |
| NCT01573468 | Capecitabine/Tesetaxel Versus Capecitabine/Placebo as Second-line Therapy for Gastric Cancer(TESEGAST) | unknown | Phase 2 | 580 | Genta IncorporatedINDUSTRY | 3 | Jul 24, 2012 | clinicaltrials |
| NCT00838240 | Clofarabine, Cytarabine, and Idarubicin in Treating Patients With Intermediate-Risk or High-Risk Acute Myeloid Leukemia or High-Risk Myelodysplasia(AML-14A) | unknown | Phase 1 / Phase 2 | 114 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 5 | Jul 20, 2012 | clinicaltrials |
| NCT01641783 | Efficacy and Safety Study of ABI-007 Plus Capecitabine as First-line Chemotherapy for Advanced Gastric Cancer Patients | unknown | Phase 2 | 40 | Yanqiao ZhangOTHER | 0 | Jul 17, 2012 | clinicaltrials |
| NCT00522405 | Randomized Control Trial (RCT) of Transarterial Chemoembolization (TACE) Versus TACE and Oral Drug Therapy in the Treatment of Unresectable Hepatocellular Carcinoma | unknown | Phase 2 / Phase 3 | — | All India Institute of Medical SciencesOTHER | 1 | Jul 16, 2012 | clinicaltrials |
| NCT01641406 | "Phase II Study of PET Guided Neoadjuvant Chemotherapy (NAC) and Oncotype Guided Hormonal Therapy of Breast Cancer"(NACprotocol) | unknown | Phase 2 | 60 | Auxilio Mutuo Cancer CenterOTHER | 1 | Jul 16, 2012 | clinicaltrials |
| NCT01438450 | Oral Chemotherapy Versus Supportive Therapy In The Treatment Of Unresectable Hepatocellular Carcinoma(OTCHCC) | unknown | Phase 2 / Phase 3 | 74 | All India Institute of Medical SciencesOTHER | 1 | Jul 13, 2012 | clinicaltrials |
| NCT01215877 | Tesetaxel for Previously Treated Patients With Bladder Cancer | unknown | Phase 2 | 33 | Genta IncorporatedINDUSTRY | 2 | Jul 11, 2012 | clinicaltrials |
| NCT01635400 | Study of Relationship Between UGT1A1 Gene Polymorphism and Toxicity and Efficacy of Irinotecan in Small Cell Lung Cancer | unknown | Phase 2 | 50 | Zhejiang Cancer HospitalOTHER | 1 | Jul 9, 2012 | clinicaltrials |
| NCT01481259 | Maintenance Therapy With Autologous Cytokine-induced Killer Cells for Nonsquamous Non-small Cell Lung Cancer | unknown | Phase 2 / Phase 3 | 120 | People's Hospital of Guangxi Zhuang Autonomous RegionOTHER | 1 | Jul 3, 2012 | clinicaltrials |
| NCT01592422 | Maintenance Therapy With Autologous Cytokine-induced Killer Cells for Small Cell Lung Cancer | unknown | Phase 2 | 60 | People's Hospital of Guangxi Zhuang Autonomous RegionOTHER | 1 | Jul 3, 2012 | clinicaltrials |
| NCT01574729 | Surgery Combined With rAd-p53 Gene in Treatment Advanced Non-small-cell Carcinoma(rAd-p53) | unknown | Phase 2 | 120 | Shenzhen SiBiono GeneTech Co.,LtdINDUSTRY | 1 | Jun 28, 2012 | clinicaltrials |
| NCT01627132 | Discontinuation of Dasatinib in Patients With Chronic Myeloid Leukemia-CP Who Have Maintained Complete Molecular Remission for Two Years; Dasatinib Stop Trial | unknown | Phase 2 | 50 | Shimousa Hematology Study GroupOTHER | 1 | Jun 25, 2012 | clinicaltrials |
| NCT01502202 | Intercalated Administration of PamCis With Gefitinib or Placebo as First Line Lung Adenocarcinoma in Never Smokers | unknown | Phase 2 | 162 | National Cancer Center, KoreaOTHER_GOV | 1 | Jun 20, 2012 | clinicaltrials |
| NCT01614938 | Induction Chemotherapy Followed by Concurrent Radiation With Cetuximab or Cisplatin in Locally Advanced Nasopharyngeal Cancer | unknown | Phase 2 | 46 | Fudan UniversityOTHER | 1 | Jun 8, 2012 | clinicaltrials |
| NCT01295593 | Low Dose CdA Combined With Valproic Acid (VPA) in Previously Treated B-cell Chronic Lymphocytic Leukemia(B-CLL) | unknown | Phase 1 / Phase 2 | 33 | Cliniques universitaires Saint-Luc- Université Catholique de LouvainOTHER | 1 | Jun 7, 2012 | clinicaltrials |
| NCT01614301 | Phase I and Consecutive Phase II, Two-arm, Randomized Multi-center Trial in Patients With Advanced Melanoma | unknown | Phase 1 / Phase 2 | 136 | University of RegensburgOTHER | 1 | Jun 7, 2012 | clinicaltrials |
| NCT00998270 | Autologous Bone Marrow Transplantation (BMT) Compared With Allogeneic BMT in Multiple Myeloma | unknown | Phase 2 / Phase 3 | 185 | Tehran University of Medical SciencesOTHER | 1 | Jun 4, 2012 | clinicaltrials |
| NCT01015742 | Unrelated Double Umbilical Cord Blood Units Transplantation | unknown | Phase 2 / Phase 3 | 10 | Tehran University of Medical SciencesOTHER | 1 | Jun 4, 2012 | clinicaltrials |
| NCT01010243 | Third-line Therapy of Multiple Myeloma a Prospective Phase I /II Trial(MM03) | unknown | Phase 1 / Phase 2 | 54 | University of RegensburgOTHER | 1 | May 30, 2012 | clinicaltrials |
| NCT01605734 | TACE Combinated With Sorafenib in Treating Patients With Unresectable Hepatocellular Carcinoma | unknown | Phase 2 | 120 | Shandong Cancer Hospital and InstituteOTHER | 1 | May 25, 2012 | clinicaltrials |
| NCT00111345 | Therapy-Optimization Trial for the Treatment of Acute Myeloid Leukemias (AML) in Children and Adolescents | unknown | Phase 2 / Phase 3 | 550 | University Hospital MuensterOTHER | 1 | May 23, 2012 | clinicaltrials |
| NCT01556815 | Sorafenib Combined With Transarterial Chemoembolization in Treating HBV-infected Patients With Intermediate Hepatocellular Carcinoma | unknown | Phase 2 | 40 | Shandong Cancer Hospital and InstituteOTHER | 1 | Apr 25, 2012 | clinicaltrials |
| NCT01584115 | Clinical Trial of a Therapeutic Vaccine With NY-ESO-1 in Combination With the Adjuvant Monophosphoryl Lipid A (MPLA) | unknown | Phase 1 / Phase 2 | 15 | Instituto de Investigação em ImunologiaOTHER | 1 | Apr 25, 2012 | clinicaltrials |
Data updated 23 days agoSource updated Jan 4, 2013source: clinicaltrials